Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial-mediated apoptosis is a crucial pathway for programmed cell death, initiated by internal stress signals and regulated by the Bcl-2 family of proteins. It involves mitochondrial outer membrane permeabilization (MOMP), cytochrome c release, and caspase activation, ultimately leading to cellular demolition. Cancer cells frequently evade this pathway, making it a key target for anticancer therapies.
Restoration of proper apoptotic signaling in cancerous tissues by targeting key components such as Bcl-2 family proteins, leading to MOMP and caspase activation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial-Mediated Apoptosis (N/A).